182 related articles for article (PubMed ID: 3461004)
1. Vitamin D compounds. Effect on clonal proliferation and differentiation of human myeloid cells.
Munker R; Norman A; Koeffler HP
J Clin Invest; 1986 Aug; 78(2):424-30. PubMed ID: 3461004
[TBL] [Abstract][Full Text] [Related]
2. Effect of a vitamin D3 analog, EB1089, on hematopoietic stem cells from normal and myeloid leukemic blasts.
Lee YY; Kim ES; Seol JG; Kim BK; Binderup L; Elstner E; Park DJ; Koeffler HP
Leukemia; 1996 Nov; 10(11):1751-7. PubMed ID: 8892678
[TBL] [Abstract][Full Text] [Related]
3. 1 alpha,25-Dihydroxy-20-epi-vitamin D3: an extraordinarily potent inhibitor of leukemic cell growth in vitro.
Elstner E; Lee YY; Hashiya M; Pakkala S; Binderup L; Norman AW; Okamura WH; Koeffler HP
Blood; 1994 Sep; 84(6):1960-7. PubMed ID: 8080998
[TBL] [Abstract][Full Text] [Related]
4. Induction of macrophage differentiation of human normal and leukemic myeloid stem cells by 1,25-dihydroxyvitamin D3 and its fluorinated analogues.
Koeffler HP; Amatruda T; Ikekawa N; Kobayashi Y; DeLuca HF
Cancer Res; 1984 Dec; 44(12 Pt 1):5624-8. PubMed ID: 6594194
[TBL] [Abstract][Full Text] [Related]
5. Novel vitamin D analogs that modulate leukemic cell growth and differentiation with little effect on either intestinal calcium absorption or bone mobilization.
Zhou JY; Norman AW; Lübbert M; Collins ED; Uskokovic MR; Koeffler HP
Blood; 1989 Jul; 74(1):82-93. PubMed ID: 2665845
[TBL] [Abstract][Full Text] [Related]
6. 1,25(OH)2-16ene-vitamin D3 is a potent antileukemic agent with low potential to cause hypercalcemia.
Jung SJ; Lee YY; Pakkala S; de Vos S; Elstner E; Norman AW; Green J; Uskokovic M; Koeffler HP
Leuk Res; 1994 Jun; 18(6):453-63. PubMed ID: 8207963
[TBL] [Abstract][Full Text] [Related]
7. 1,25-Dihydroxyvitamin D3: in vivo and in vitro effects on human preleukemic and leukemic cells.
Koeffler HP; Hirji K; Itri L
Cancer Treat Rep; 1985 Dec; 69(12):1399-407. PubMed ID: 2416438
[TBL] [Abstract][Full Text] [Related]
8. Divergent regulation of 1,25-dihydroxyvitamin D3 on human bone marrow osteoclastogenesis and myelopoiesis.
Qi DY; Perkins SL; Kling SJ; Russell RG
J Cell Biochem; 1999 Mar; 72(3):387-95. PubMed ID: 10022520
[TBL] [Abstract][Full Text] [Related]
9. Retinoids. Structure-function relationship in normal and leukemic hematopoiesis in vitro.
Tobler A; Dawson MI; Koeffler HP
J Clin Invest; 1986 Jul; 78(1):303-9. PubMed ID: 3459735
[TBL] [Abstract][Full Text] [Related]
10. 19-nor-26,27-bishomo-vitamin D3 analogs: a unique class of potent inhibitors of proliferation of prostate, breast, and hematopoietic cancer cells.
Kubota T; Koshizuka K; Koike M; Uskokovic M; Miyoshi I; Koeffler HP
Cancer Res; 1998 Aug; 58(15):3370-5. PubMed ID: 9699668
[TBL] [Abstract][Full Text] [Related]
11. A new series of vitamin D analogs is highly active for clonal inhibition, differentiation, and induction of WAF1 in myeloid leukemia.
Munker R; Kobayashi T; Elstner E; Norman AW; Uskokovic M; Zhang W; Andreeff M; Koeffler HP
Blood; 1996 Sep; 88(6):2201-9. PubMed ID: 8822940
[TBL] [Abstract][Full Text] [Related]
12. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
[TBL] [Abstract][Full Text] [Related]
13. Alternative differentiation of human promyelocytic leukemia cells (HL-60) induced selectively by retinoic acid and 1 alpha,25-dihydroxyvitamin D3.
Miyaura C; Abe E; Suda T; Kuroki T
Cancer Res; 1985 Sep; 45(9):4244-8. PubMed ID: 2992776
[TBL] [Abstract][Full Text] [Related]
14. Effects of 1,25-dihydroxyvitamin D3 and its 20-epi analogues (MC 1288, MC 1301, KH 1060), on clonal keratinocyte growth: evidence for differentiation of keratinocyte stem cells and analysis of the modulatory effects of cytokines.
Gniadecki R
Br J Pharmacol; 1997 Mar; 120(6):1119-27. PubMed ID: 9134225
[TBL] [Abstract][Full Text] [Related]
15. Combination of a potent 20-epi-vitamin D3 analogue (KH 1060) with 9-cis-retinoic acid irreversibly inhibits clonal growth, decreases bcl-2 expression, and induces apoptosis in HL-60 leukemic cells.
Elstner E; Linker-Israeli M; Umiel T; Le J; Grillier I; Said J; Shintaku IP; Krajewski S; Reed JC; Binderup L; Koeffler HP
Cancer Res; 1996 Aug; 56(15):3570-6. PubMed ID: 8758928
[TBL] [Abstract][Full Text] [Related]
16. Myeloid progenitors from the bone marrow of patients with vitamin D resistant rickets (type II) fail to respond to 1,25(OH)2D3.
Nagler A; Merchav S; Fabian I; Tatarsky I; Weisman Y; Hochberg Z
Br J Haematol; 1987 Nov; 67(3):267-71. PubMed ID: 2825755
[TBL] [Abstract][Full Text] [Related]
17. Vitamin D3 analogs: effect on leukemic clonal growth and differentiation, and on serum calcium levels.
Pakkala S; de Vos S; Elstner E; Rude RK; Uskokovic M; Binderup L; Koeffler HP
Leuk Res; 1995 Jan; 19(1):65-72. PubMed ID: 7837819
[TBL] [Abstract][Full Text] [Related]
18. The role of the c-fms oncogene in the regulation of HL-60 cell differentiation.
Wu J; Zhu JQ; Han KK; Zhu DX
Oncogene; 1990 Jun; 5(6):873-7. PubMed ID: 2141686
[TBL] [Abstract][Full Text] [Related]
19. In vitro interaction of recombinant tumor necrosis factor alpha and all-trans-retinoic acid with normal and leukemic hematopoietic cells.
Tobler A; Munker R; Heitjan D; Koeffler HP
Blood; 1987 Dec; 70(6):1940-6. PubMed ID: 2823943
[TBL] [Abstract][Full Text] [Related]
20. Biological activities of 26,26,26,27,27,27-hexafluoro-1,25-dihydroxyvitamin D3 on human promyelocytic leukemic HL-60 cells: effects of fetal bovine serum and of incubation time.
Okuno S; Inaba M; Nishizawa Y; Morii H
Miner Electrolyte Metab; 1995; 21(1-3):211-6. PubMed ID: 7565452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
